Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
After more than twenty-five years of negotiations, the European Union and the Mercosur countries — Brazil, Argentina, Uruguay and Paraguay — finalized their trade agreement. Provisionally applied since 1 May 2026, the agreement marks a major step in economic relations between Europe and South America. For European companies in cosmetics, fragrance and home fragrance, the issue is twofold: benefiting from progressively improved commercial access to high-potential markets, while continuing to comply with regulatory requirements that remain largely national. Although the EU–Mercosur agreement creates new opportunities, it does not remove product registration obligations, labelling requirements or the need for a local responsible party in the countries concerned. For European brands, success will depend not only on commercial strategy, but also on early regulatory planning.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Ukraine has adopted a new cosmetic regulation aligned with EU Regulation (EC) No 1223/2009, introducing stricter safety, compliance, and market surveillance requirements.
Learn how cosmetic regulations work in Canada, including Health Canada requirements, Cosmetic Notification Forms, ingredient restrictions, labeling rules, and key updates in 2026.
FDA updated the Cosmetics Direct portal to support MoCRA biennial renewal. Learn what cosmetic facilities must verify before renewing their registration in 2026.
Learn about Canada’s 2026 monograph updates for primary and secondary sunscreens and acne products, and understand the practical implications for compliance and product authorization.
Active substance renewal under the GB Biocidal Products Regulation (GB BPR) is a critical regulatory challenge for companies placing biocidal products on the Great Britain market. With strict 550-day submission deadlines and major expiries in 2026 and 2027, early planning is essential to avoid market disruption and loss of product authorisations.
The European Commission has adopted a corrective regulation to clarify the REACH restriction on microplastics, addressing medicines, product and process-oriented R&D (PPORD) and solid matrix uses, while preserving the regulation’s environmental objectives.
.png)
